← All trials
NCT06612203
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2025
- Primary completion
- Feb 28, 2027
- Completion date
- Oct 31, 2027
- First posted
- Sep 25, 2024
- Last posted
- Sep 27, 2024
- Enrollment
- 76
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- MedSIRLead sponsor
- Gilead SciencesCollaborator
- DebiopharmCollaborator
- University of BristolOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.